SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Medican Enterprises, Inc. (MDCN) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 45/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MDCN
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2011 |
$0.00 |
$0.00 |
$-8.04K |
- |
| 2012 |
$-0.01 |
$0.00 |
$-18.9K |
- |
| 2013 |
$-0.14 |
$0.00 |
$-376K |
- |
| 2014 |
$-13.70 |
$0.00 |
$-56.52M |
- |
| 2019 |
$0.00 |
$624K |
$118.42K |
19% |
| 2020 |
$0.00 |
$1.1M |
$3.85M |
348.5% |
| 2021 |
$0.00 |
$4.24M |
$152.65K |
3.6% |
| 2022 |
$0.00 |
$2.61M |
$6.35M |
243.5% |
| 2023 |
$0.00 |
$0.00 |
$675.31K |
- |
| 2024 |
$0.00 |
$0.00 |
$-1.21M |
- |
